Recent MSK Discoveries & Advances

Our Research Impact
Paul Marks Prize for Cancer Research
Recent MSK Discoveries & Advances
Research Awards & Honors
Researcher Interviews
Emeritus Faculty

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
375 News Items found
In the Lab
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
In the Lab
The 1986 explosion at the Chernobyl nuclear power plant released radioactive particles in every direction.
Study Reveals Genetic Causes for Thyroid Cancer Increase after Chernobyl

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.
Announcement
Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Innovative Partnership Will Speed Drug Discovery and Development

Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.
In the Lab
Mouse glioblastoma tumor with phagocytic macrophages
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Snapshot
Breast cancer mosaic
New Technology Could Enable Immediate Detection of Tumor Borders during Surgery

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.
Snapshot
Pictured: Pseudomonas aeruginosa
The Social Behavior of Bacteria Offers New Ideas for Antimicrobial Drug Design

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.
In the Lab
Pictured: Daniel Thorek & Jan Grimm
Faster than the Speed of Light: New Imaging Approach Could Measure Tumor Activity

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.
Q&A
Pictured: Derek Tan
Taking Clues from Nature for the Development of New Drugs

In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.
In the Lab
Pictured: Kenneth Offit
Gene Mutation Linked to Inherited Risk of Common Form of Childhood Leukemia

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.
In the Lab
Pictured: Cancer cell lines
Do Cancer Cell Lines Really Resemble Tumors? Now Researchers Can Tell

A recent study found that the cell lines most commonly used for research on ovarian cancer are not the most suitable.